  NOVO INDUSTRI EARNINGS FALL DESPITE INCREASED SALES      COPENHAGEN, March 11 - Danish-bas insulin enzym produc Novo Industri A/S (NVO.CO) pre-tax earn fell 10 pct 1986 though sale rose two pct. 
    The pre-tax figur fell 788 mln crown 872 mln 1985, sale increas 4.1 billion 4.2 billion, give net earn 521 mln crown against 604 mln 1985. 
    Earn per 20-crown share went 23.79 crown 20.45 crown compani propos unchang 20 pct dividend. 
    Foreign exchang fluctuat 1986 veri signific factor behind develop result befor tax, Novo statement. 
    Not U.S. 
Dollar currenc essenti Novo fell 1986 relat Danish crown, statement added. 
    In Novemb 1986, Novo purchas 75 pct share A/S Ferrosan, head group specialis research develop CNS (central nervou treatment) treatment sale pharmaceut vitamin Scandinavia. 
    The 357 mln crown paid goodwil veri limit effect 1986 result, Novo statement said.
